Atlanta Addiction Treatment Center Announces New Outpatient Alcohol Detox Program
WellStep, an office-based treatment program located in Roswell, Georgia in suburban Atlanta announces its new outpatient alcohol detox program allowing appropriate patients to safely and comfortably discontinue moderate to heavy alcohol use without hospitalization.
Atlanta, GA (PRWEB) June 05, 2011
WellStep, an office based addiction treatment program located in suburban Atlanta, Georgia (http://www.WellStep.com) is pleased to announce its new one week outpatient alcohol detox program designed to help patients safely and comfortably stop drinking without having to be admitted to a hospital.
Up to 70% of individuals presenting for alcohol detoxification have significant symptoms of alcohol withdrawal.
In WellStep Atlanta’s outpatient program, patients initially undergo a medical evaluation that includes a history, physical and lab work.
If found appropriate to participate in outatient detox, patients are given instructions on when to totally stop drinking and are scheduled to return to the clinic, when they will receive medication to reduce withdrawal symptoms and to prevent complications of alcohol detoxification such as seizures and delirium tremens (DT’s). This medication typically includes either carbamazepine (Tegretol) or benzodiazepines such as chlordiazepoxide (Librium).
Patients must have a responsible adult at home with them to administer medication, for transportation, and for general monitoring.
More information can be found on http://www.WellStep.com.
Mark S. Banov, MD, MPH, FACPM, Medical Director of WellStep, is a specialist in Addiction Medicine certified by the American Board of Addiction Medicine. Along with his clinical responsibilities, Dr. Banov serves as a Principal Investigator and Clinical Investigator in FDA-regulated trials studying new treatments for alcoholism, opiate dependence, and depression, attention deficit disorder and anxiety disorder.
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/6/prweb8528291.htm